Work

Real-world efficacy and safety of cadonilimab (PD-1/CTLA-4 bispecific antibody) in patients with advanced, recurrent, and metastatic cervical cancer.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.5537

Authors: Dapeng Li, Shengfei Zhao, Jinhua Fan, Hui Guo, Shuai Feng

Institutions: Shandong Tumor Hospital, Shandong First Medical University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410812822

Cites:

Cited by: 1

Related to: 10